Page last updated: 2024-10-29

isocarboxazid and Movement Disorders

isocarboxazid has been researched along with Movement Disorders in 1 studies

Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bucci, L1

Trials

1 trial available for isocarboxazid and Movement Disorders

ArticleYear
The dyskenesias: a new therapeutic approach.
    Diseases of the nervous system, 1971, Volume: 32, Issue:5

    Topics: Chlorpromazine; Clinical Trials as Topic; Female; Humans; Isocarboxazid; Male; Middle Aged; Monoamin

1971